Dopamine D2 receptors contribute to increased avidity for sucrose in obese rats lacking CCK-1 receptors

Neuroscience

Volumn 148, Issue 2, 2007, Pages 584-592

  Hajnal, A ^a   De Jonghe, B C ^b   Covasa, M ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

food intake; palatability; reward; type 2 diabetes

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CHOLECYSTOKININ A RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RACLOPRIDE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; IMPAIRED GLUCOSE TOLERANCE; MALE; NONHUMAN; OBESITY; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PALATABILITY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR SENSITIVITY; REWARD; SIGNAL TRANSDUCTION; SUGAR INTAKE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; MALE; RACLOPRIDE; RATS; RATS, INBRED OLETF; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, DOPAMINE D2; SUCROSE; SWEETENING AGENTS; TASTE; TIME FACTORS;

EID: 34548396800     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.06.025     Document Type: Article

References (53)

1. Baker R.W., Osman J., and Bodnar R.J. Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet. Pharmacol Biochem Behav 69 (2001) 201-208
2. Baldo B.A., Sadeghian K., Basso A.M., and Kelley A.E. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behav Brain Res 137 (2002) 165-177
3. Bednar I., Carrer H., Qureshi G.A., and Sodersten P. Dopamine D1 or D2 antagonists enhance inhibition of consummatory ingestive behavior by CCK-8. Am J Physiol 269 (1995) R896-R903
4. Beinfeld M.C. What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization. Life Sci 73 (2003) 643-654
5. Cincotta A.H., Tozzo E., and Scislowski P.W. Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. Life Sci 61 (1997) 951-956
6. Cooper S.J., and Al-Naser H.A. Dopaminergic control of food choice: contrasting effects of SKF 38393 and quinpirole on high-palatability food preference in the rat. Neuropharmacology 50 (2006) 953-963
7. Covasa M., and Ritter R.C. Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22 (2001) 1339-1348
8. Covasa M., and Ritter R.C. Reduced CCK-induced Fos expression in the hindbrain, nodose ganglia, and enteric neurons of rats lacking CCK-1 receptors. Brain Res 1051 (2005) 155-163
9. Crawley J.N. Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12 (1991) 232-236
10. De Jonghe B.C., Di Martino C., Hajnal A., and Covasa M. Brief intermittent access to sucrose differentially modulates prepulse inhibition and acoustic startle response in obese CCK-1 receptor deficient rats. Brain Res 1052 (2005) 22-27
11. De Jonghe B.C., Hajnal A., and Covasa M. Increased oral and decreased intestinal sensitivity to sucrose in obese, prediabetic CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol 288 (2005) R292-R300
12. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use 12 (1998) 54-67
13. Drewnowski A. Energy density, palatability, and satiety: implications for weight control. Nutr Rev 56 (1998) 347-353
14. Feifel D., Priebe K., and Shilling P.D. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology 24 (2001) 663-670
15. Frank G.K., Bailer U.F., Henry S.E., Drevets W., Meltzer C.C., Price J.C., Mathis C.A., Wagner A., Hoge J., Ziolko S., Barbarich-Marsteller N., Weissfeld L., and Kaye W.H. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry 58 (2005) 908-912
16. Hajnal A., Covasa M., and Bello N.T. Altered taste sensitivity in obese, pre-diabetic OLETF rats lacking CCK-1 receptors. Am J Physiol Regul Integr Comp Physiol 289 (2005) R1675-R1686
17. Hajnal A., and Norgren R. Accumbens dopamine mechanisms in sucrose intake 904 (2001) 76
18. Hajnal A., Smith G.P., and Norgren R. Oral sucrose stimulation increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 286 (2004) R31-R37
19. Hamilton M.E., and Freeman A.S. Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Res 688 (1995) 134-142
20. Hamilton M.E., Redondo J.L., and Freeman A.S. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration. Synapse 38 (2000) 238-242
21. Hill D.R., Shaw T.M., Graham W., and Woodruff G.N. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329. J Neurosci 10 (1990) 1070-1081
22. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., and Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285 (1980) 476-478
23. Hsiao S., and Smith G.P. Raclopride reduces sucrose preference in rats. Pharmacol Biochem Behav 50 (1995) 121-125
24. Hurd Y.L., Lindefors N., Brodin E., Brene S., Persson H., Ungerstedt U., and Hokfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Res 578 (1992) 317-326
25. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422-1428
26. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22 (2002) 3306-3311
27. Levine A.S., Kotz C.M., and Gosnell B.A. Sugars: hedonic aspects, neuroregulation, and energy balance. Am J Clin Nutr 78 (2003) 834S-842S
28. Maidment N.T., and Villafranca N.P. Persistence of the releasable pool of CCK in the rat nucleus accumbens and caudate-putamen following lesions of the midbrain. Brain Res 747 (1997) 290-296
29. Margas W.M., Acharya N.K., Covasa M., and Hajnal A. Obese OLETF rats show augmented ingestive and motor responses to dopamine D2 receptor stimulation. Society for the Study of Ingestive Behavior: Annual Meeting vol. 44 (2005) 329-392 Appetite.
30. Meguid M.M., Fetissov S.O., Varma M., Sato T., Zhang L., Laviano A., and Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16 (2000) 843-857
31. Moran T.H. Cholecystokinin and satiety: current perspectives. Nutrition 16 (2000) 858-865
32. Moran T.H., and Bi S. Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects. Dev Psychobiol 48 (2006) 360-367
33. Nomoto S., Miyake M., Ohta M., Funakoshi A., and Miyasaka K. Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor. Physiol Behav 66 (1999) 869-872
34. Okauchi N., Mizuno A., Yoshimoto S., Zhu M., Sano T., and Shima K. Is caloric restriction effective in preventing diabetes mellitus in the Otsuka Long Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 27 (1995) 97-106
35. Orosco M., Gerozissis K., Rouch C., Meile M.J., and Nicolaidis S. Hypothalamic monoamines and insulin in relation to feeding in the genetically obese Zucker rat as revealed by microdialysis. Obes Res 3 Suppl 5 (1995) 655S-665S
36. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a 'thrifty' genotype underlying the metabolic syndrome. Eur J Pharmacol 480 (2003) 125-131
37. Prentice A.M., and Jebb S.A. Fast foods, energy density and obesity: a possible mechanistic link. Obes Rev 4 (2003) 187-194
38. Schneider L.H. Orosensory self-stimulation by sucrose involves brain dopaminergic mechanisms 575 (1989) 307
39. Seroogy K., Schalling M., Brene S., Dagerlind A., Chai S.Y., Hokfelt T., Persson H., Brownstein M., Huan R., Dixon J., et al. Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry. Exp Brain Res 74 (1989) 149-162
40. Shima K., Shi K., Mizuno A., Sano T., Ishida K., and Noma Y. Exercise training has a long-lasting effect on prevention of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima Fatty rats. Metabolism 45 (1996) 475-480
41. Smith G.P. Accumbens dopamine is a physiological correlate of the rewarding and motivating effects of food. In: Stricker E.M., and Woods S.C. (Eds). Neurobiology of food and fluid intake, Vol. 14 of Handbook of behavioral neurobiology (2004), Kluwer Academic/Plenum Publishers, New York 15-42
42. Smith G.P. Accumbens dopamine mediates the rewarding effect of orosensory stimulation by sucrose. Appetite 43 (2004) 11-13
43. Sorensen L.B., Moller P., Flint A., Martens M., and Raben A. Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. Int J Obes Relat Metab Disord 27 (2003) 1152-1166
44. Szczypka M.S., Rainey M.A., and Palmiter R.D. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 25 (2000) 102-104
45. Taha S.A., and Fields H.L. Encoding of palatability and appetitive behaviors by distinct neuronal populations in the nucleus accumbens. J Neurosci 25 (2005) 1193-1202
46. Takiguchi S., Takata Y., Funakoshi A., Miyasaka K., Kataoka K., Fujimura Y., Goto T., and Kono A. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 197 (1997) 169-175
47. Volkow N.D., and Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160 (2003) 1909-1918
48. Wang G.J., Volkow N.D., and Fowler J.S. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 6 (2002) 601-609
49. Wang G.J., Volkow N.D., Thanos P.K., and Fowler J.S. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 23 (2004) 39-53
50. Weatherford S.C., Greenberg D., Gibbs J., and Smith G.P. The potency of D-1 and D-2 receptor antagonists is inversely related to the reward value of sham-fed corn oil and sucrose in rats. Pharmacol Biochem Behav 37 (1990) 317-323
51. Wise R.A. Forebrain substrates of reward and motivation. J Comp Neurol 493 (2005) 115-121
52. Yeomans M.R., Blundell J.E., and Leshem M. Palatability: response to nutritional need or need-free stimulation of appetite. Br J Nutr 92 Suppl 1 (2004) S3-S14
53. Yu W.Z., Silva R.M., Sclafani A., Delamater A.R., and Bodnar R.J. Pharmacology of flavor preference conditioning in sham-feeding rats: effects of dopamine receptor antagonists. Pharmacol Biochem Behav 65 (2000) 635-647